AstraZeneca PLC is 101.9x more valuable than Structure Therapeutics Inc. by market capitalization ($286.27 B vs $2.81 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GPCR | AZN |
|---|---|---|
| Market cap | $2.81 B | $286.27 B |
| US-listed rank | #1858 | #45 |
| Net income (latest FY) | -$141.20M | - |
| SEC filings | 248 | 1,004 |
AstraZeneca PLC is 101.9x more valuable than Structure Therapeutics Inc. by market capitalization ($286.27 B vs $2.81 B).
Full pages: Structure Therapeutics Inc. and AstraZeneca PLC, or browse the full rankings.